Literature DB >> 10719017

Rapid method for the analysis of peripheral chimerism in suspected graft-versus-host disease after liver transplantation.

A B Hahn1, P Baliga.   

Abstract

The effects of microchimerism and possible tolerance have been well studied in orthotopic liver transplantation. In some patients, greater levels of donor cells persist in the periphery. These cells were characterized and their effects on clinical outcome were studied. Peripheral blood was obtained from patients at various times posttransplantation. HLA class II typing was performed by the polymerase chain reaction-sequence-specific primer method on unfractionated blood and lymphocyte subpopulations. Relative levels of amplification of donor and recipient alleles were compared. All patients studied had a low degree of chimerism that was most apparent in the CD8(+)T/natural killer (NK) cell population. One patient with persistently high levels of donor alleles in his CD8(+)T/NK cell population was diagnosed with severe graft-versus-host disease (GVHD) and died of opportunistic infections. Another patient with biopsy-proven GVHD was chimeric in several cell populations. On resolution of her symptoms, donor alleles were reduced to levels undetectable by this assay. These results suggest that persistently elevated levels of donor CD8(+)T/NK cells in the periphery may indicate GVHD in liver transplant recipients. This technique aids in rapid diagnosis, which facilitates appropriate treatment and thus may improve clinical outcome.

Entities:  

Mesh:

Year:  2000        PMID: 10719017     DOI: 10.1002/lt.500060214

Source DB:  PubMed          Journal:  Liver Transpl        ISSN: 1527-6465            Impact factor:   5.799


  9 in total

1.  Unsuccessful treatment of four patients with acute graft-vs-host disease after liver transplantation.

Authors:  Xiao-Bo Chen; Jie Yang; Ming-Qing Xu; Tian-Fu Wen; Lu-Nan Yan
Journal:  World J Gastroenterol       Date:  2012-01-07       Impact factor: 5.742

Review 2.  Graft-versus-host disease after liver transplantation: a comprehensive literature review.

Authors:  Sami Akbulut; Mehmet Yilmaz; Sezai Yilmaz
Journal:  World J Gastroenterol       Date:  2012-10-07       Impact factor: 5.742

Review 3.  Immunological basis for treatment of graft versus host disease after liver transplant.

Authors:  Vikrant Rai; Nicholas Edward Dietz; Devendra K Agrawal
Journal:  Expert Rev Clin Immunol       Date:  2016-02-24       Impact factor: 4.473

4.  Graft-verse-host disease after liver transplantation: a report of two cases and review of literature.

Authors:  Zhi-Yong Guo; Xiao-Shun He; Lin-Wei Wu; Xiao-Feng Zhu; Wei-Qiang Ju; Dong-Ping Wang; Shen You; Yi Ma; Guo-Dong Wang; Jie-Fu Huang
Journal:  World J Gastroenterol       Date:  2008-02-14       Impact factor: 5.742

5.  Macrochimerism in Intestinal Transplantation: Association With Lower Rejection Rates and Multivisceral Transplants, Without GVHD.

Authors:  J Zuber; S Rosen; B Shonts; B Sprangers; T M Savage; S Richman; S Yang; S P Lau; S DeWolf; D Farber; G Vlad; E Zorn; W Wong; J Emond; B Levin; M Martinez; T Kato; M Sykes
Journal:  Am J Transplant       Date:  2015-05-18       Impact factor: 8.086

6.  Correlation of Chimerism with Acute Graft-versus-Host Disease in Rats following Liver Transplantation.

Authors:  Fei Xue; Wei Chen; Xue-Li Bai; Guo-Dong Xu; Liang Liang; Ting-Bo Liang
Journal:  Int J Hepatol       Date:  2011-05-17

7.  Acute Graft-Versus-Host Disease After Orthotopic Liver Transplantation: Predicting This Rare Complication Using Machine Learning.

Authors:  Jason P Cooper; James D Perkins; Paul R Warner; Alexandra Shingina; Scott W Biggins; Janis L Abkowitz; Jorge D Reyes
Journal:  Liver Transpl       Date:  2021-11-05       Impact factor: 6.112

8.  Acute graft-versus-host disease after liver transplantation in a close contact with COVID-19: A case report.

Authors:  Lu Wang; Bo Yang; Lai Wei; Dong Chen; Yuanyuan Zhao; Zhishui Chen
Journal:  Transpl Immunol       Date:  2021-06-30       Impact factor: 1.708

Review 9.  Acute graft versus host disease after orthotopic liver transplantation.

Authors:  Inga Mandac Rogulj; Joachim Deeg; Stephanie J Lee
Journal:  J Hematol Oncol       Date:  2012-08-13       Impact factor: 17.388

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.